Studio TIARA: Alessitimia Ed Emicrania Cronica
- Conditions
- MigraineAlexithymia
- Registration Number
- NCT06891053
- Lead Sponsor
- Azienda Sanitaria Locale di Alessandria
- Brief Summary
The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity of the clinical phenotype of migraine, favoring its chronicization), in an analysis adjusted for psychiatric comorbidity (for anxiety and depression, potentially influencing migraine chronicization) and for personalogical factor represented by apathy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- Female
- Target Recruitment
- 350
- Diagnosis of episodic migraine with or without aura, chronic migraine and/or MOH according to ICHD-3 2018 criteria;
- Patients aged 12-65 years;
- Female patients
- Ongoing major depressive episode;
- Comorbidities for major internal diseases (hepatopathy, nephropathy, heart failure, etc.);
- Alcohol or substance abuse disorder (eoin, cocaine, cannabis, hallucinogens);
- Language barrier;
- Low cultural/cognitive level;
- No informed consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Degree of alexithymia In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval Independent variable measured as a score on the TAS-20 scale
Migraine frequency In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval
- Secondary Outcome Measures
Name Time Method Number of "drug days" in patients diagnosed with MOH In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval Degree of alessithymia in patients diagnosed with MOH In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Azienda Sanitaria Locale di Alessandria (ASL AL)
🇮🇹Alessandria, Italy
Azienda Sanitaria Locale di Alessandria (ASL AL)🇮🇹Alessandria, Italy